Revenue
2015
2016
2017
2021
2022
2023
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0 | $1,240 | $1,240 | — | — | $2,250 | $43,143 | $28,375 | — |
| Gross profit | — | — | — | $0 | $679 | $679 | — | — | $893 | $41,786 | $26,339 | — |
| Research & development | $125,079 | $180,987 | $175,268 | $711,506 | $279,912 | $365,132 | — | — | — | $3,692 | $28,328 | $61,747 |
| Operating expenses | $445,187 | $513,251 | $744,810 | $1.4M | $2.6M | $1.3M | $121,317 | $134,376 | $334,883 | $334,218 | $201,465 | $208,878 |
| Operating income | −$445,187 | −$513,251 | −$744,810 | −$1.4M | −$2.6M | −$1.3M | −$121,317 | −$134,376 | −$333,990 | −$292,432 | −$175,126 | −$208,878 |
| EBITDAderived | — | — | — | — | — | — | — | — | — | −$291,979 | −$174,739 | −$208,449 |
| Net income | −$485,636 | −$567,048 | −$585,154 | −$1.4M | −$2.6M | −$1.3M | −$132,652 | −$42.8M | −$381,101 | −$295,637 | −$175,126 | −$208,878 |
| Basic EPSper diluted share | — | — | — | — | — | -$0.04 | -$6.45 | -$3,875.40 | -$0.06 | -$0.05 | -$0.03 | -$0.04 |
| Diluted EPSper diluted share | -$0.01 | -$0.01 | -$0.01 | — | — | -$0.04 | -$6.45 | -$3,875.40 | -$0.06 | -$0.05 | -$0.03 | -$0.04 |